Cambrex (CBM) Jumps: Stock Adds 13.1% in Session

Zacks Equity Research
January 29, 2014

Cambrex Corporation (CBM) was a big mover last session with its shares rising over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the trend of the company since Jan 13, as the stock is now up nearly 4%.

This life sciences company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate has also remained unchanged over the same period. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cambrex currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked BioMed stocks worth considering are Affymetrix Inc. (AFFX), Actelion Ltd. (ALIOF) and Heska Corp. (HSKA). While Affymetrix and Actelion sport a Zacks Rank #1 (Strong Buy), Heska holds a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



CAMBREX CORP (CBM): Free Stock Analysis Report

AFFYMETRIX INC (AFFX): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

HESKA CORP (HSKA): Free Stock Analysis Report


Zacks Investment Research